Evercore & Jefferies
8 shared events · Importance 4 · Last updated Jul 23, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Evercore: Evercore acted as a joint book-running manager for Kailera Therapeutics's IPO, facilitating the offering and earning underwriting fees.
Jefferies: Jefferies acted as a joint book-running manager for Kailera Therapeutics's IPO, facilitating the offering and earning underwriting fees.
Apr 16, 2026 · 8 articles
Business
Evercore: Evercore is acting as a joint book-running manager, earning fees from the offering.
Jefferies: Jefferies is acting as a joint book-running manager, benefiting from underwriting fees.
Jul 13, 2026 · 11 articles
Business
Evercore: Acted as joint book-running manager, earning underwriting fees and reinforcing its role in biotech equity offerings.
Jefferies: Acted as joint book-running manager, earning underwriting fees and reinforcing its role in biotech equity offerings.
Jul 21, 2026 · 6 articles
Business
Evercore: Evercore ISI is acting as a joint book-running manager for the proposed secondary offering of Pattern Group Inc. shares.
Jefferies: Jefferies is acting as a joint book-running manager for the proposed secondary offering of Pattern Group Inc. shares.
Jun 15, 2026 · 6 articles
Business
Evercore: Evercore acted as an active book-running manager for Quantinuum's IPO, assisting in the management and distribution of the shares.
Jefferies: Jefferies acted as an active book-running manager for Quantinuum's IPO, contributing to the successful execution of the offering.
May 26, 2026 · 76 articles
Business
Evercore: Evercore is a joint bookrunner, involved in the IPO.
Jefferies: Jefferies is a global coordinator and joint bookrunner, benefiting from the large IPO.
Jul 20, 2026 · 6 articles
Business
Evercore: Evercore acted as a financial advisor to ArisGlobal in the transaction, earning advisory fees.
Jefferies: Jefferies acted as a financial advisor to ArisGlobal in the transaction, earning advisory fees.
Jul 23, 2026 · 6 articles
Business
Evercore: Evercore is acting as a joint book-running manager for the public offering of Spyre Therapeutics' common stock.
Apr 13, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Evercore and Jefferies interact across events, view sentiment trends, and discover connected entities.
Open Dashboard